JPH0420916B2 - - Google Patents

Info

Publication number
JPH0420916B2
JPH0420916B2 JP58051053A JP5105383A JPH0420916B2 JP H0420916 B2 JPH0420916 B2 JP H0420916B2 JP 58051053 A JP58051053 A JP 58051053A JP 5105383 A JP5105383 A JP 5105383A JP H0420916 B2 JPH0420916 B2 JP H0420916B2
Authority
JP
Japan
Prior art keywords
formula
general formula
group
compound represented
pyridine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58051053A
Other languages
English (en)
Japanese (ja)
Other versions
JPS59204191A (ja
Inventor
Tsutomu Irikura
Seigo Suzue
Hideo Ookubo
Katsuya Awano
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kyorin Pharmaceutical Co Ltd
Original Assignee
Kyorin Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Pharmaceutical Co Ltd filed Critical Kyorin Pharmaceutical Co Ltd
Priority to JP58051053A priority Critical patent/JPS59204191A/ja
Priority to HU841103A priority patent/HU189844B/hu
Priority to US06/591,381 priority patent/US4559402A/en
Priority to CA000449985A priority patent/CA1246575A/en
Priority to NO84841109A priority patent/NO162964C/no
Priority to EP84103233A priority patent/EP0121197B1/en
Priority to DK165184A priority patent/DK154218C/da
Priority to DE8484103233T priority patent/DE3461377D1/de
Priority to KR1019840001544A priority patent/KR900001548B1/ko
Priority to ES530989A priority patent/ES8602785A1/es
Publication of JPS59204191A publication Critical patent/JPS59204191A/ja
Publication of JPH0420916B2 publication Critical patent/JPH0420916B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP58051053A 1983-03-26 1983-03-26 ピラゾロピリジン誘導体、その製法及びそれを含有する治療剤 Granted JPS59204191A (ja)

Priority Applications (10)

Application Number Priority Date Filing Date Title
JP58051053A JPS59204191A (ja) 1983-03-26 1983-03-26 ピラゾロピリジン誘導体、その製法及びそれを含有する治療剤
HU841103A HU189844B (en) 1983-03-26 1984-03-20 Process for preparing pyrazolo/1,5-a/pyridine derivatives
US06/591,381 US4559402A (en) 1983-03-26 1984-03-20 Pyrazolopyridines and tetrahydro pyrazolopyridines
CA000449985A CA1246575A (en) 1983-03-26 1984-03-20 Pyrazolopyridine derivatives, therapeutic compositions comprising same, and process thereof
NO84841109A NO162964C (no) 1983-03-26 1984-03-21 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridinderivater.
EP84103233A EP0121197B1 (en) 1983-03-26 1984-03-23 Pyrazolopyridine derivatives, therapeutic compositions comprising same, and process thereof
DK165184A DK154218C (da) 1983-03-26 1984-03-23 Pyrazolopyridinderivater eller farmaceutisk acceptable salte deraf samt farmaceutisk praeparat indeholdende en eller flere af disse forbindelser
DE8484103233T DE3461377D1 (en) 1983-03-26 1984-03-23 Pyrazolopyridine derivatives, therapeutic compositions comprising same, and process thereof
KR1019840001544A KR900001548B1 (ko) 1983-03-26 1984-03-26 피라졸로 피리딘 유도체의 제조방법
ES530989A ES8602785A1 (es) 1983-03-26 1984-03-26 Procedimiento para preparar derivados de pirazolpiridina

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58051053A JPS59204191A (ja) 1983-03-26 1983-03-26 ピラゾロピリジン誘導体、その製法及びそれを含有する治療剤

Publications (2)

Publication Number Publication Date
JPS59204191A JPS59204191A (ja) 1984-11-19
JPH0420916B2 true JPH0420916B2 (en, 2012) 1992-04-07

Family

ID=12876060

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58051053A Granted JPS59204191A (ja) 1983-03-26 1983-03-26 ピラゾロピリジン誘導体、その製法及びそれを含有する治療剤

Country Status (10)

Country Link
US (1) US4559402A (en, 2012)
EP (1) EP0121197B1 (en, 2012)
JP (1) JPS59204191A (en, 2012)
KR (1) KR900001548B1 (en, 2012)
CA (1) CA1246575A (en, 2012)
DE (1) DE3461377D1 (en, 2012)
DK (1) DK154218C (en, 2012)
ES (1) ES8602785A1 (en, 2012)
HU (1) HU189844B (en, 2012)
NO (1) NO162964C (en, 2012)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2177601A (en) * 1985-07-11 1987-01-28 Shell Int Research Use of pyridine and pyridazine derivatives as fungacides
FR2594438B1 (fr) * 1986-02-14 1990-01-26 Labaz Sanofi Nv Derives d'indolizine, leur procede de preparation ainsi que les compositions en contenant
US5179103A (en) * 1987-06-15 1993-01-12 Fujisawa Pharmaceutical Company, Ltd. Pharmaceutically useful pyrazolopyridines
FR2687675B1 (fr) * 1992-01-31 1997-04-18 Roussel Uclaf Nouveaux derives bicycliques de la pyridine, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant.

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5154583A (en) * 1974-11-01 1976-05-13 Kyorin Seiyaku Kk Shinkipirazoro * 1 55a * pirijinjudotaino seizoho
US4097483A (en) * 1974-11-01 1978-06-27 Kyorin Pharmaceutical Co., Ltd. Pyrazolo 1,5-a!pyridines

Also Published As

Publication number Publication date
HUT34026A (en) 1985-01-28
NO841109L (no) 1984-09-27
ES530989A0 (es) 1985-12-01
DK165184A (da) 1984-09-27
EP0121197A1 (en) 1984-10-10
HU189844B (en) 1986-08-28
KR900001548B1 (ko) 1990-03-12
EP0121197B1 (en) 1986-11-20
DK154218C (da) 1989-03-13
DE3461377D1 (en) 1987-01-08
ES8602785A1 (es) 1985-12-01
NO162964B (no) 1989-12-04
JPS59204191A (ja) 1984-11-19
US4559402A (en) 1985-12-17
DK165184D0 (da) 1984-03-23
CA1246575A (en) 1988-12-13
NO162964C (no) 1990-03-14
KR840008154A (ko) 1984-12-13
DK154218B (da) 1988-10-24

Similar Documents

Publication Publication Date Title
US5087629A (en) Pharmacologically active pyrazolopyridine compounds
RU2067975C1 (ru) 1,2-дигидро-2-оксопиридины, их физиологически приемлемые соли и фармацевтическая композиция
US4668686A (en) Imidazoquinoline antithrombrogenic cardiotonic agents
JP4316794B2 (ja) イソキノリン誘導体及び医薬
JPH05508660A (ja) ジアリールメチルピペリジンまたはピペラジンのピリジンおよびピリジンｎ−オキシド誘導体、並びにそれらの組成物および使用方法
JP3122792B2 (ja) 新規な活性化合物
IL100887A (en) Imidazopyridines process for their preparation and paf/h1 antagonist compositions containing them
JPH01254678A (ja) ジヒドロピリジン化合物
JP3853389B2 (ja) 新規の３−フェニルスルホニル−３，７−ジアザビシクロ［３，３，１］ノナン−化合物、その製法及び抗不整脈剤
US4783467A (en) Tetrahydroimidazoquinazolinone inotropic agents
JPH0420916B2 (en, 2012)
US5179103A (en) Pharmaceutically useful pyrazolopyridines
JPS63225356A (ja) ジヒドロピリジン誘導体
US5753678A (en) Heterocyclic compounds
US5565470A (en) Cycloaminoalkoxyphenyl derivatives, a process for their preparation as well as the compositions containing them
JPH069402A (ja) 抗潰瘍剤
JPS6348273A (ja) キノロン強心剤
JPH03141257A (ja) ジヒドロピリジン誘導体
JPH0662608B2 (ja) カルボスチリル誘導体
JPS58148883A (ja) ピリドベンゾジアゼピノン化合物
JPH09249661A (ja) オキシインドール誘導体
JPH05507932A (ja) イミダゾピリジンｐａｆ拮抗薬
JP2955768B2 (ja) 新規なジアゾシン誘導体
JP3000300B2 (ja) 血管内膜肥厚抑制剤
JPH04503516A (ja) ジヒドロピリミジン抗アレルギー剤